Skip to main content
. 2017 Jun 8;8:15761. doi: 10.1038/ncomms15761

Figure 1. Structures of lorlatinib and labelling precursors.

Figure 1

The target compound lorlatinib is shown at the top. Sites of derivatization are shown in blue for reactions with [11C]CH3I (middle) or green for [18F]fluoride (bottom). The iodonium ylide precursor was prepared from (R)-6.